Background: Dry needling is an effective treatment for reducing pain associated with active myofascial trigger points (a-MTrPs) in the short term. The duration of the benefits of this treatment have not been fully assessed.
Objective: To determine whether the benefits of dry needling (DN) of a-MTrPs are sustained 6 weeks posttreatment.
Objective: To determine whether standard evaluations of pain distinguish subjects with no pain from those with myofascial pain syndromes (MPS) and active myofascial trigger points (MTrPs) and to assess whether self-reports of mood, function, and health-related quality of life differ between these groups.
Design: A prospective, descriptive study.
Setting: University.